Thursday September 30 |
07h30
Welcoming coffee
08.00
Welcome address
Jean-Olivier Defraigne, Liège, Belgium
Helena Kuivaniemi, Danville, USA
------------------------------------------------------------------------------------
------------------------------------------------------------------------------------
08h10 Genetic basis of syndromic TAAD
Bart Loeys, Gent, Belgium
08h30 Genetic basis of thoracic aortic aneurysms and aortic dissections: gene-based management
Dianna Milewicz, Houston, Texas, USA
08h50 Gene expression profiles associated with TAA in patients with bicuspid aortic valve
Per Eriksson, Stockholm, Sweden
09h10 3’-UTR and coding-sequence miR-29 binding sites repress elastin gene expression in postnatal aortic development
Peter N. Robinson, Berlin, Germany
09h30 Short presentations
The Role of Complement Cascade in Abdominal Aortic Aneurysms
Hinterseher Irene, Danville, United States
Genotype-phenotype correlation in 104 patients with vascular Ehlers-Danlos syndrome in a French cohort: Evidence for a mild form of the disease.
Bal Laurence, Paris, France
High resolution melting analysis to detect rare genetic variants associated with abdominal aortic aneurysm
Harrison Seamus, London, United Kingdom
09h50 Coffee break
10h20 Genome wide study on AAA
Solveig Gretarsdottir, Reykjavik, Iceland
10h40 The aneurysm consortium AAA GWAS
Matthew Bown, Leicester, United Kingdom
11h00 Assessing the potential value of tissue and circulating markers of abdominal aortic aneurysm
Jonathan Golledge, Townsville, Australia
11h20 Genetic and genomic studies of AAA
David Carey, Pennsylvania, USA
11h40 Distinct defects in collagen micro architecture underlie vessel wall failure in AAA and aneurysms in Marfan syndrome
Jan Lindeman, Leiden, The Netherlands
12h00 Differential regulation of Lamin A/C in AAA - a putative new target for therapy
Gillian W Cockerill, London, United Kingdom
12h20 Short presentations
Relationship between osteopontin plasma levels and ascending aortic dilation
Bevilacqua Stefano, Massa, Italy
Altered microRNAs in bicuspid aortic valve
Mohamed Salaheldien Ali, Luebeck, Germany
12h30 Lunch
13h30 Industry symposium
CARDOZ
A new medical approach to treat AAA
Moderators: Jesper Swedenborg
13h30 Introduction Jesper Swedenborg
13h35 Pharmacological approaches in AAA Johan Raud
13h45 The role ofmast cells inAAA Jesper Swedenborg
14h05 A clinical study of amast cell inhibitor in AAA Carl-JohanDalsgaard
14h15 Questions & closing remarks Jesper Swedenborg
13h30 Posters presentations
Moderators: Betty Nusgens & Per Eriksson
Cystatin C correlates with short-term abdominal aortic aneurysm growth
Melina Vega de Céniga, Galdakao-Usansolo (Bizkaia), Spain
Apoptotic tendency and genomic abnormalities of smooth muscle cells in thoracic aortic aneurysms
Acilan Ceyda, Gebze-Kocaeli, Turkey
C-reactive protein (CRP) and aortic aneurysm: real-time PCR analysis
Tozzi Matteo, Varese, Italy
Apoptosis and elevation of Matrixmetalloproteinases in Ascending Aneurysms with a Bicuspid Aortic Valve
Mohamed Salaheldien Ali, Luebeck, Germany
Expression of Matrix Metalloproteinase-2, -9 and Collagen I, III in Ascending Thoracic Aortic Aneurysms
Baysal Kemal, Gebze, Turkey
Discovery of a novel circulating biomarker in patients with abdominal aortic aneurysm
Wallinder Jonas, Sundsvall, Sweden
------------------------------------------------------------------------------------
------------------------------------------------------------------------------------
14.30 Physiopathology of ascending aorta with bicuspid and tricuspid aortic valve
Alessandro Della Corte, Naples, Italy
14.45 Involvement of the intra luminal thrombus in aneurysmal acceleration towards rupture
Jean-Baptiste Michel, Paris, France
15.00 Blood tests for thoracic aortic aneurysm
John Elefteriades, New Haven, CT, USA
15.15 Novel biomarkers of AAA evolution
Jose Luis Martin-Ventura, Madrid, Spain
15.30 2 D electrophoresis based proteomic investigation of serum in AAA-patients
Sigitas Urbonavicius Viborg, Denmark
15.45 Molecular pathogenesis of AAA
Koichi Yoshimura, Ube, Japan
16.00 Short presentations
Impaired splicing of fibronectin is associated with thoracic aortic aneurysm formation in patients with bicuspid aortic valve
Paloschi Valentina, Stockholm, Sweden
Fibrin architecture is altered in abdominal aortic aneurysms and correlates with aneurysm size
Ariëns Robert A S, Leeds, United Kingdom
Uptake of 18-fluorodeoxyglucose (FDG) as detected by Positron Emission Tomography
(PET) is correlated to an increased expression of proteolytic enzymes in the wall of abdominal aortic aneurysms (AAA)
Courtois Audrey, Liège, Belgium
16.15 Discussion
16.30 Coffee break
------------------------------------------------------------------------------------
PART ONE - SESSION I
ASCENDING AORTA AND ARCH
-------------------------------------
17.00 Place of the endovascular treatment in type A dissection
Stephan Haulon, Lille, France
17.15 EVAR in the aortic arch
Tilo Kölbel, Hamburg, Germany
17.30 Outcomes of the endovascular management of aortic arch aneurysm
Matthew Thompson, London, United Kingdom
17.45 Bovine aortic arch: not a benign variant
John Elefteriades, New Haven, CT, USA
18h00 Management of complicated type B dissection
Christoph Nienaber, Rostock, Germany
18.15 Discussion